CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 40 filers reported holding CYCLERION THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $156,211 | -33.9% | 360,016 | -0.1% | 0.00% | – |
| Q4 2022 | $236,433 | -23.7% | 360,306 | -0.1% | 0.00% | – |
| Q3 2022 | $310,000 | +56.6% | 360,676 | -0.3% | 0.00% | – |
| Q2 2022 | $198,000 | -59.6% | 361,580 | -18.1% | 0.00% | – |
| Q1 2022 | $490,000 | -35.9% | 441,380 | -0.9% | 0.00% | – |
| Q4 2021 | $765,000 | -42.7% | 445,166 | +2.3% | 0.00% | – |
| Q3 2021 | $1,336,000 | -21.5% | 435,155 | -0.2% | 0.00% | – |
| Q2 2021 | $1,701,000 | -63.8% | 436,147 | -74.1% | 0.00% | – |
| Q1 2021 | $4,703,000 | -4.2% | 1,685,485 | +5.1% | 0.00% | – |
| Q4 2020 | $4,909,000 | -47.0% | 1,604,118 | +5.3% | 0.00% | – |
| Q3 2020 | $9,262,000 | +0.0% | 1,523,349 | -2.8% | 0.00% | – |
| Q2 2020 | $9,261,000 | +119.9% | 1,566,862 | -1.4% | 0.00% | – |
| Q1 2020 | $4,211,000 | -4.3% | 1,589,262 | -1.7% | 0.00% | – |
| Q4 2019 | $4,398,000 | -76.0% | 1,616,681 | +7.1% | 0.00% | -100.0% |
| Q3 2019 | $18,294,000 | +8.1% | 1,509,457 | +2.1% | 0.00% | 0.0% |
| Q2 2019 | $16,920,000 | – | 1,477,745 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Slate Path Capital LP | 7,157,601 | $3,105,683 | 0.15% |
| Artal Group S.A. | 2,779,122 | $1,206 | 0.07% |
| MFN Partners Management, LP | 3,389,215 | $1,470,580 | 0.07% |
| Intrinsic Value Partners, LLC | 43,105 | $18,703 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,000 | $49,899 | 0.00% |
| Penobscot Investment Management Company, Inc. | 10,000 | $4,339 | 0.00% |
| COLONY GROUP LLC | 102,884 | $44 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 292,645 | $126,979 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 592,237 | $256,971 | 0.00% |
| STATE STREET CORP | 115,414 | $50,078 | 0.00% |